Total Payments
$156,335
2024 Payments
$13,873
Companies
36
Transactions
317
Medicare Patients
3,257
Medicare Billing
$213,792
Payment Breakdown by Category
Other$105,091 (67.2%)
Consulting$24,580 (15.7%)
Travel$19,611 (12.5%)
Food & Beverage$6,838 (4.4%)
Education$186.26 (0.1%)
Gifts$29.11 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $54,716 | 30 | 35.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $47,125 | 15 | 30.1% |
| Consulting Fee | $24,580 | 15 | 15.7% |
| Travel and Lodging | $19,611 | 86 | 12.5% |
| Food and Beverage | $6,838 | 136 | 4.4% |
| Honoraria | $3,250 | 2 | 2.1% |
| Education | $186.26 | 6 | 0.1% |
| Gift | $29.11 | 21 | 0.0% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
General
$156,335
311 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valeant Pharmaceuticals North America LLC | $59,588 | 74 | $0 (2017) |
| AMAG Pharmaceuticals, Inc. | $51,258 | 98 | $0 (2018) |
| ASCEND THERAPEUTICS US, LLC | $17,924 | 29 | $0 (2024) |
| DySIS Medical, Inc. | $9,654 | 15 | $0 (2022) |
| Astellas Pharma US Inc | $8,706 | 12 | $0 (2024) |
| Sprout Pharmaceuticals, Inc. | $4,180 | 1 | $0 (2018) |
| TherapeuticsMD, Inc. | $2,448 | 9 | $0 (2020) |
| ABBVIE INC. | $427.49 | 15 | $0 (2024) |
| SCYNEXIS, Inc. | $383.39 | 3 | $0 (2022) |
| Myovant Sciences Inc. | $289.62 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,873 | 18 | ASCEND THERAPEUTICS US, LLC ($13,001) |
| 2023 | $11,855 | 24 | Astellas Pharma US Inc ($8,023) |
| 2022 | $10,900 | 34 | DySIS Medical, Inc. ($8,932) |
| 2021 | $1,251 | 23 | DySIS Medical, Inc. ($700.00) |
| 2020 | $371.02 | 16 | MERZ NORTH AMERICA, INC. ($124.37) |
| 2019 | $2,649 | 14 | TherapeuticsMD, Inc. ($2,421) |
| 2018 | $47,291 | 90 | AMAG Pharmaceuticals, Inc. ($42,931) |
| 2017 | $68,144 | 98 | Valeant Pharmaceuticals North America LLC ($59,588) |
All Payment Transactions
317 individual payment records from CMS Open Payments — Page 2 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Women's Health | ||||||
| 08/22/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.50 | General |
| Category: Women's Health | ||||||
| 08/22/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.20 | General |
| Category: Women's Health | ||||||
| 08/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,150.00 | General |
| Category: Biological | ||||||
| 08/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $99.78 | General |
| Category: Biological | ||||||
| 06/13/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Biological | ||||||
| 05/18/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.78 | General |
| Category: Women's Health | ||||||
| 05/02/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.78 | General |
| Category: Women's Health | ||||||
| 04/20/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: HORMONE THERAPY | ||||||
| 04/18/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $1.56 | General |
| Category: Women's Health | ||||||
| 04/03/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Obesity | ||||||
| 03/16/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.78 | General |
| Category: Women's Health | ||||||
| 03/13/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $24.88 | General |
| 03/08/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Women's Health | ||||||
| 01/26/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.78 | General |
| Category: Women's Health | ||||||
| 01/05/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.78 | General |
| Category: Women's Health | ||||||
| 2023 | Unified Women's Healthcare, LP | — | — | — | $0.00 | Ownership |
| 12/22/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,125.00 | General |
| Category: Women's Health | ||||||
| 12/14/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $0.78 | General |
| Category: Women's Health | ||||||
| 11/16/2022 | Mycovia Pharmaceuticals, Inc. | Vivjoa (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Infections and Infectious Diseases | ||||||
| 11/14/2022 | DySIS Medical, Inc. | DYSIS ULTRA (Device), DYSIS ULTRA 2.0, DYSIS v3 Digital Coploscope | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: OBSTETRICS & GYNECOLOGY | ||||||
| 10/31/2022 | ASCEND Therapeutics US, LLC | ESTROGEL (Drug) | Gift | In-kind items and services | $1.45 | General |
| Category: Women's Health | ||||||
| 10/28/2022 | Antares Pharma, Inc. | TLANDO (Drug), XYOSTED | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/19/2022 | DySIS Medical, Inc. | DYSIS ULTRA (Device), DYSIS ULTRA 2.0, DYSIS v3 Digital Coploscope | Travel and Lodging | Cash or cash equivalent | $410.14 | General |
| Category: OBSTETRICS & GYNECOLOGY | ||||||
| 10/19/2022 | DySIS Medical, Inc. | DYSIS ULTRA (Device), DYSIS ULTRA 2.0, DYSIS v3 Digital Coploscope | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: OBSTETRICS & GYNECOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 859 | 916 | $247,197 | $60,879 |
| 2022 | 18 | 750 | 826 | $214,831 | $51,632 |
| 2021 | 11 | 784 | 847 | $130,955 | $51,265 |
| 2020 | 16 | 864 | 1,049 | $165,055 | $50,017 |
Total Patients
3,257
Total Services
3,638
Medicare Billing
$213,792
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 186 | $73,284 | $17,510 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 90 | 90 | $45,900 | $11,702 | 25.5% |
| 77067 | Screening mammography | Office | 2023 | 54 | 54 | $28,620 | $6,870 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 74 | $20,572 | $4,391 | 21.3% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 44 | 48 | $18,336 | $4,114 | 22.4% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 55 | 55 | $13,750 | $2,903 | 21.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 55 | 55 | $6,875 | $2,292 | 33.3% |
| 76641 | Complete ultrasound scan of 1 breast | Office | 2023 | 25 | 26 | $8,829 | $2,150 | 24.3% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 90 | 90 | $4,500 | $1,592 | 35.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 84 | 84 | $4,788 | $1,592 | 33.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 31 | 31 | $4,092 | $1,375 | 33.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $5,130 | $1,131 | 22.1% |
| 57160 | Fitting and insertion of vaginal support device | Office | 2023 | 13 | 18 | $4,050 | $1,119 | 27.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 22 | 23 | $5,520 | $903.21 | 16.4% |
| A4562 | Pessary, non rubber, any type | Office | 2023 | 11 | 15 | $1,650 | $800.55 | 48.5% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 11 | 11 | $891.00 | $296.23 | 33.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 39 | 41 | $410.00 | $136.40 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 118 | 160 | $44,480 | $10,144 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 115 | $45,310 | $9,446 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $31,620 | $7,339 | 23.2% |
| 77067 | Screening mammography | Office | 2022 | 42 | 42 | $22,260 | $5,446 | 24.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $11,628 | $2,832 | 24.4% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 25 | 25 | $9,550 | $2,491 | 26.1% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 42 | 42 | $10,500 | $2,242 | 21.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 48 | 48 | $6,000 | $2,026 | 33.8% |
About Dr. Maureen Whelihan, M.D
Dr. Maureen Whelihan, M.D is a Gynecology healthcare provider based in Greenacres, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104913102.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maureen Whelihan, M.D has received a total of $156,335 in payments from pharmaceutical and medical device companies, with $13,873 received in 2024. These payments were reported across 317 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($54,716).
As a Medicare-enrolled provider, Whelihan has provided services to 3,257 Medicare beneficiaries, totaling 3,638 services with total Medicare billing of $213,792. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Greenacres, FL
- Active Since 10/10/2006
- Last Updated 12/15/2025
- Taxonomy Code 207VG0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104913102
Products in Payments
- ADDYI (Drug) $59,588
- INTRAROSA (Drug) $47,750
- ESTROGEL (Drug) $17,917
- DYSIS ULTRA (Device) $8,932
- Veozah (Drug) $8,041
- addyi (Drug) $4,180
- BREMELANOTIDE (Drug) $3,493
- IMVEXXY (Drug) $2,305
- DYSIS Ultra (Device) $700.00
- MYFEMBREE (Drug) $328.78
- EVENITY (Biological) $232.88
- LO LOESTRIN FE (Drug) $202.33
- Orilissa (Drug) $161.24
- Wegovy (Drug) $129.01
- XEOMIN (Biological) $124.37
- BIJUVA (Drug) $115.95
- Myosure and NovaSure (Device) $109.52
- Phexxi (Drug) $93.09
- Lupron (Drug) $90.26
- SLYND (Drug) $85.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.